Free Trial

NEXGEL Q2 2024 Earnings Report

NEXGEL logo
$2.88 -0.17 (-5.57%)
As of 03/28/2025 04:00 PM Eastern

NEXGEL EPS Results

Actual EPS
-$0.14
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NEXGEL Revenue Results

Actual Revenue
$1.44 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NEXGEL Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Remove Ads

NEXGEL Earnings Headlines

NEXGEL, Inc. (NASDAQ:NXGL) Q4 2024 Earnings Call Transcript
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
NEXGEL Reports Record Revenue Growth in 2024
See More NEXGEL Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NEXGEL? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NEXGEL and other key companies, straight to your email.

About NEXGEL

NEXGEL (NASDAQ:NXGL) manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.

View NEXGEL Profile

More Earnings Resources from MarketBeat